Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Apr;91(4):1507–1515. doi: 10.1172/JCI116356

Leukotriene D4 is a mediator of proteinuria and glomerular hemodynamic abnormalities in passive Heymann nephritis.

T Katoh 1, E A Lianos 1, M Fukunaga 1, K Takahashi 1, K F Badr 1
PMCID: PMC288126  PMID: 8386188

Abstract

We assessed the role of leukotrienes (LTs) in Munich-Wistar rats with passive Heymann nephritis (PHN), an animal model of human membranous nephropathy. 10 d after injection of anti-Fx1A antibody, urinary protein excretion rate (Upr) in PHN was significantly higher than that of control. Micropuncture studies demonstrated reduced single nephron plasma flow and glomerular filtration rates, increased transcapillary hydraulic pressure difference, pre- and postglomerular resistances, and decreased ultrafiltration coefficient in PHN rats. Glomerular LTB4 generation from PHN rats was increased. Administration of the 5-LO activating protein inhibitor MK886 for 10 d markedly blunted proteinuria and normalized glomerular hemodynamic abnormalities in PHN rats. An LTD4 receptor antagonist SK&F 104353 led to an immediate reduction in Upr and to reversal of glomerular hemodynamic impairment. Ia(+) cells/glomerulus were increased in PHN rats. In x-irradiated PHN rats, which developed glomerular macrophage depletion, augmented glomerular LT synthesis was abolished. Thus, in the autologous phase of PHN, LTD4 mediates glomerular hemodynamic abnormalities and a hemodynamic component of the accompanying proteinuria. The synthesis of LTD4 likely occurs directly from macrophages or from macrophage-derived LTA4, through LTC4 synthase in glomerular cells.

Full text

PDF
1507

Images in this article

1513Image
on p.1513

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Badr K. F., Baylis C., Pfeffer J. M., Pfeffer M. A., Soberman R. J., Lewis R. A., Austen K. F., Corey E. J., Brenner B. M. Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the rat. Circ Res. 1984 May;54(5):492–499. doi: 10.1161/01.res.54.5.492. [DOI] [PubMed] [Google Scholar]
  2. Badr K. F., Brenner B. M., Ichikawa I. Effects of leukotriene D4 on glomerular dynamics in the rat. Am J Physiol. 1987 Aug;253(2 Pt 2):F239–F243. doi: 10.1152/ajprenal.1987.253.2.F239. [DOI] [PubMed] [Google Scholar]
  3. Badr K. F., DeBoer D. K., Takahashi K., Harris R. C., Fogo A., Jacobson H. R. Glomerular responses to platelet-activating factor in the rat: role of thromboxane A2. Am J Physiol. 1989 Jan;256(1 Pt 2):F35–F43. doi: 10.1152/ajprenal.1989.256.1.F35. [DOI] [PubMed] [Google Scholar]
  4. Badr K. F., Mong S., Hoover R. L., Schwartzberg M., Ebert J., Jacobson H. R., Harris R. C. Leukotriene D4 binding and signal transduction in rat glomerular mesangial cells. Am J Physiol. 1989 Aug;257(2 Pt 2):F280–F287. doi: 10.1152/ajprenal.1989.257.2.F280. [DOI] [PubMed] [Google Scholar]
  5. Badr K. F., Schreiner G. F., Wasserman M., Ichikawa I. Preservation of the glomerular capillary ultrafiltration coefficient during rat nephrotoxic serum nephritis by a specific leukotriene D4 receptor antagonist. J Clin Invest. 1988 Jun;81(6):1702–1709. doi: 10.1172/JCI113509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baud L., Sraer J., Perez J., Nivez M. P., Ardaillou R. Leukotriene C4 binds to human glomerular epithelial cells and promotes their proliferation in vitro. J Clin Invest. 1985 Jul;76(1):374–377. doi: 10.1172/JCI111972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  8. Butler J. E., Cantarero L. A., McGivern P. L. Measurement of bovine subclass antibodies (IgG1 and IgG2) using the amplified enzyme-linked immunosorbent assay. Mol Immunol. 1980 May;17(5):645–653. doi: 10.1016/0161-5890(80)90163-7. [DOI] [PubMed] [Google Scholar]
  9. Clark M. A., Littlejohn D., Conway T. M., Mong S., Steiner S., Crooke S. T. Leukotriene D4 treatment of bovine aortic endothelial cells and murine smooth muscle cells in culture results in an increase in phospholipase A2 activity. J Biol Chem. 1986 Aug 15;261(23):10713–10718. [PubMed] [Google Scholar]
  10. Cybulsky A. V., Lieberthal W., Quigg R. J., Rennke H. G., Salant D. J. A role for thromboxane in complement-mediated glomerular injury. Am J Pathol. 1987 Jul;128(1):45–51. [PMC free article] [PubMed] [Google Scholar]
  11. Cybulsky A. V., Quigg R. J., Salant D. J. The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy. J Immunol. 1986 Sep 1;137(5):1511–1516. [PubMed] [Google Scholar]
  12. Deen W. M., Troy J. L., Robertson C. R., Brenner B. M. Dynamics of glomerular ultrafiltration in the rat. IV. Determination of the ultrafiltration coefficient. J Clin Invest. 1973 Jun;52(6):1500–1508. doi: 10.1172/JCI107324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dixon R. A., Diehl R. E., Opas E., Rands E., Vickers P. J., Evans J. F., Gillard J. W., Miller D. K. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature. 1990 Jan 18;343(6255):282–284. doi: 10.1038/343282a0. [DOI] [PubMed] [Google Scholar]
  14. Edgington T. S., Glassock R. J., Dixon F. J. Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med. 1968 Mar 1;127(3):555–572. doi: 10.1084/jem.127.3.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gabbai F. B., Gushwa L. C., Wilson C. B., Blantz R. C. An evaluation of the development of experimental membranous nephropathy. Kidney Int. 1987 Jun;31(6):1267–1278. doi: 10.1038/ki.1987.140. [DOI] [PubMed] [Google Scholar]
  16. Gillard J., Ford-Hutchinson A. W., Chan C., Charleson S., Denis D., Foster A., Fortin R., Leger S., McFarlane C. S., Morton H. L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol. 1989 May;67(5):456–464. doi: 10.1139/y89-073. [DOI] [PubMed] [Google Scholar]
  17. Hara M., Batsford S. R., Mihatsch M. J., Bitter-Suermann D., Vogt A. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria. Lab Invest. 1991 Aug;65(2):168–179. [PubMed] [Google Scholar]
  18. Ichikawa I., Hoyer J. R., Seiler M. W., Brenner B. M. Mechanism of glomerulotubular balance in the setting of heterogeneous glomerular injury. Preservation of a close functional linkage between individual nephrons and surrounding microvasculature. J Clin Invest. 1982 Jan;69(1):185–198. doi: 10.1172/JCI110430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Keane W. F., Kasiske B. L., O'Donnell M. P. Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis. Am J Nephrol. 1988;8(4):261–271. doi: 10.1159/000167599. [DOI] [PubMed] [Google Scholar]
  20. Kim D., Lewis D. L., Graziadei L., Neer E. J., Bar-Sagi D., Clapham D. E. G-protein beta gamma-subunits activate the cardiac muscarinic K+-channel via phospholipase A2. Nature. 1989 Feb 9;337(6207):557–560. doi: 10.1038/337557a0. [DOI] [PubMed] [Google Scholar]
  21. Kurachi Y., Ito H., Sugimoto T., Shimizu T., Miki I., Ui M. Arachidonic acid metabolites as intracellular modulators of the G protein-gated cardiac K+ channel. Nature. 1989 Feb 9;337(6207):555–557. doi: 10.1038/337555a0. [DOI] [PubMed] [Google Scholar]
  22. Lianos E. A., Noble B. Glomerular leukotriene synthesis in Heymann nephritis. Kidney Int. 1989 Dec;36(6):998–1002. doi: 10.1038/ki.1989.293. [DOI] [PubMed] [Google Scholar]
  23. Lianos E. A. Synthesis of hydroxyeicosatetraenoic acids and leukotrienes in rat nephrotoxic serum glomerulonephritis. Role of anti-glomerular basement membrane antibody dose, complement, and neutrophiles. J Clin Invest. 1988 Aug;82(2):427–435. doi: 10.1172/JCI113615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lotan D., Kaplan B. S., Fong J. S., Goodyer P. R., de Chadarevian J. P. Reduction of protein excretion by dimethyl sulfoxide in rats with passive Heymann nephritis. Kidney Int. 1984 May;25(5):778–788. doi: 10.1038/ki.1984.90. [DOI] [PubMed] [Google Scholar]
  25. Nicholson G. D., Amin U. F., Alleyne G. A. Membranous glomerulonephropathy with crescents. Clin Nephrol. 1975 Nov;4(5):198–201. [PubMed] [Google Scholar]
  26. Rouzer C. A., Ford-Hutchinson A. W., Morton H. E., Gillard J. W. MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J Biol Chem. 1990 Jan 25;265(3):1436–1442. [PubMed] [Google Scholar]
  27. Salant D. J., Quigg R. J., Cybulsky A. V. Heymann nephritis: mechanisms of renal injury. Kidney Int. 1989 Apr;35(4):976–984. doi: 10.1038/ki.1989.81. [DOI] [PubMed] [Google Scholar]
  28. Samuelsson B., Dahlén S. E., Lindgren J. A., Rouzer C. A., Serhan C. N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 1987 Sep 4;237(4819):1171–1176. doi: 10.1126/science.2820055. [DOI] [PubMed] [Google Scholar]
  29. Schreiner G. F., Kohan D. E. Regulation of renal transport processes and hemodynamics by macrophages and lymphocytes. Am J Physiol. 1990 Apr;258(4 Pt 2):F761–F767. doi: 10.1152/ajprenal.1990.258.4.F761. [DOI] [PubMed] [Google Scholar]
  30. Schreiner G. F., Rovin B., Lefkowith J. B. The antiinflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis. The modulation of macrophage migration and eicosanoid metabolism. J Immunol. 1989 Nov 15;143(10):3192–3199. [PubMed] [Google Scholar]
  31. Serhan C. N. Lipoxins: eicosanoids carrying intra- and intercellular messages. J Bioenerg Biomembr. 1991 Feb;23(1):105–122. doi: 10.1007/BF00768841. [DOI] [PubMed] [Google Scholar]
  32. Serhan C. N., Sheppard K. A. Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. J Clin Invest. 1990 Mar;85(3):772–780. doi: 10.1172/JCI114503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Shah S. V. Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats. Am J Physiol. 1988 Mar;254(3 Pt 2):F337–F344. doi: 10.1152/ajprenal.1988.254.3.F337. [DOI] [PubMed] [Google Scholar]
  34. Spurney R. F., Ruiz P., Pisetsky D. S., Coffman T. M. Enhanced renal leukotriene production in murine lupus: role of lipoxygenase metabolites. Kidney Int. 1991 Jan;39(1):95–102. doi: 10.1038/ki.1991.12. [DOI] [PubMed] [Google Scholar]
  35. Stahl R. A., Adler S., Baker P. J., Chen Y. P., Pritzl P. M., Couser W. G. Enhanced glomerular prostaglandin formation in experimental membranous nephropathy. Kidney Int. 1987 May;31(5):1126–1131. doi: 10.1038/ki.1987.118. [DOI] [PubMed] [Google Scholar]
  36. Viets J. W., Deen W. M., Troy J. L., Brenner B. M. Determination of serum protein concentration in nanoliter blood samples using fluorescamine or 9-phthalaldehyde. Anal Biochem. 1978 Aug 1;88(2):513–521. doi: 10.1016/0003-2697(78)90451-7. [DOI] [PubMed] [Google Scholar]
  37. Ylä-Herttuala S., Rosenfeld M. E., Parthasarathy S., Glass C. K., Sigal E., Witztum J. L., Steinberg D. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci U S A. 1990 Sep;87(18):6959–6963. doi: 10.1073/pnas.87.18.6959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Yoshioka T., Rennke H. G., Salant D. J., Deen W. M., Ichikawa I. Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: a study in early passive Heymann nephritis. Circ Res. 1987 Oct;61(4):531–538. doi: 10.1161/01.res.61.4.531. [DOI] [PubMed] [Google Scholar]
  39. Zoja C., Benigni A., Verroust P., Ronco P., Bertani T., Remuzzi G. Indomethacin reduces proteinuria in passive Heymann nephritis in rats. Kidney Int. 1987 Jun;31(6):1335–1343. doi: 10.1038/ki.1987.147. [DOI] [PubMed] [Google Scholar]
  40. van Goor H., Fidler V., Weening J. J., Grond J. Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Evidence for involvement of macrophages and lipids. Lab Invest. 1991 Jun;64(6):754–765. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES